These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8303939)

  • 1. Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults.
    Christenson B; Böttiger M
    Vaccine; 1994 Jan; 12(1):41-5. PubMed ID: 8303939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty years' experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination.
    Böttiger M; Forsgren M
    Vaccine; 1997 Oct; 15(14):1538-44. PubMed ID: 9330465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts.
    Davidkin I; Valle M
    Vaccine; 1998 Dec; 16(20):2052-7. PubMed ID: 9796064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule.
    Christenson B; Böttiger M
    Vaccine; 1991 May; 9(5):326-9. PubMed ID: 1872016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against measles, mumps and rubella (MMR): a comparison between the antibody responses at the ages of 18 months and 12 years and between different methods of antibody titration.
    Christenson B; Böttiger M
    J Biol Stand; 1985 Apr; 13(2):167-72. PubMed ID: 3997899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland.
    Davidkin I; Peltola H; Leinikki P; Valle M
    Vaccine; 2000 Jul; 18(27):3106-12. PubMed ID: 10856790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months.
    Böttiger M
    Vaccine; 1995 Dec; 13(18):1759-62. PubMed ID: 8701590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass vaccination programme aimed at eradicating measles, mumps and rubella in Sweden: vaccination of schoolchildren.
    Böttiger M; Christenson B; Taranger J; Bergman M
    Vaccine; 1985 Jun; 3(2):113-6. PubMed ID: 4036269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
    Christenson B; Böttiger M
    Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines.
    Miller E; Hill A; Morgan-Capner P; Forsey T; Rush M
    Vaccine; 1995 Jun; 13(9):799-802. PubMed ID: 7483800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A; Gerike E
    Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme.
    Broliden K; Abreu ER; Arneborn M; Böttiger M
    Vaccine; 1998; 16(2-3):323-7. PubMed ID: 9607050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.
    Coté TR; Sivertson D; Horan JM; Lindegren ML; Dwyer DM
    Public Health Rep; 1993; 108(4):431-5. PubMed ID: 8341775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boosting effect of a second dose of measles vaccine given to 12-year-old children.
    Böttiger M
    Scand J Infect Dis; 1993; 25(2):239-43. PubMed ID: 8511518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up.
    Davidkin I; Valle M; Julkunen I
    Vaccine; 1995 Nov; 13(16):1617-22. PubMed ID: 8578851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
    Ljungman P; Fridell E; Lönnqvist B; Bolme P; Böttiger M; Gahrton G; Linde A; Ringdén O; Wahren B
    J Infect Dis; 1989 Apr; 159(4):610-5. PubMed ID: 2647859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation.
    Pauksen K; Duraj V; Ljungman P; Sjölin J; Oberg G; Lönnerholm G; Fridell E; Smedmyr B; Simonsson B
    Bone Marrow Transplant; 1992 Jun; 9(6):427-32. PubMed ID: 1628126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles, mumps, and rubella antibodies in vaccinated Baltimore children.
    King JC; Lichenstein R; Feigelman S; Luna C; Permutt TJ; Patel J
    Am J Dis Child; 1993 May; 147(5):558-60. PubMed ID: 8488803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.